Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
Pennsylvania is planning to limit Medicaid coverage to beneficiaries at the highest risk of complications from obesity
The 24.2% average weight loss seen with Retatrutide approaches the results typically achieved with bariatric surgery, which produces 25-30% weight loss
Importantly, most GLP-1 receptor agonists carry a boxed warning about the risk of thyroid C-cell tumors and are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
These are completely different products with different mechanisms, different dosing, and different expectations
US$ 25.65
US$ 23.07
US$ 28.78
US$ 20.31
US$ 26.95
US$ 20.89
